Romero Montserrat Del Carmen Valencia, Cárdenas Adrián Morales, Fuentes Alberto Briseño, Barragán Adrian Alberto Salinas, Gómez Daniel Bladimir Serrano, Jiménez Marisol Tello
Resident of General Surgery, Hospital Civil Dr. Juan I. Menchaca, Mexico.
Surgical Oncology, Regional Hospital IMSS 46, Mexico.
Int J Surg Case Rep. 2021 Aug 11;86:106307. doi: 10.1016/j.ijscr.2021.106307. eCollection 2021 Sep.
CoV-2 infection generates a pro-inflammatory state, which conditions the formation of thrombi that can affect any system. Multi-organ dysfunction is a cause of death, mesenteric ischemia in COVID 2019 patients reported is 1.9-4%.
We present the case of a 73-year-old male patient who started with severe SARS-CoV-2 and arterial-type intestinal ischemia, necrosis of 3 m of the small intestine, based on SCARE 2020 guide.
Complications secondary to thrombosis are as follows; myocardial infarction 1.1%, ischemic cerebral events, 2.5-3.7%, microvascular thrombosis including mesenteric ischemia in less than 1% of cases. In patients with mesenteric ischemia the reported postoperative mortality is 23.8% of patients especially during the first 30 days.
Intestinal thrombosis in patients with SARS-CoV-2 increases mortality.
新型冠状病毒2感染会引发促炎状态，这种状态会促使血栓形成，进而可能影响任何系统。多器官功能障碍是死亡原因之一，据报道，2019冠状病毒病患者肠系膜缺血的发生率为1.9%至4%。
我们报告一例73岁男性患者，根据2020年SCARE指南，该患者最初患有严重的新型冠状病毒2感染及动脉型肠缺血，小肠3米坏死。
血栓形成的继发性并发症如下：心肌梗死1.1%，缺血性脑事件2.5%至3.7%，微血管血栓形成（包括肠系膜缺血）发生率低于1%。肠系膜缺血患者术后死亡率据报道为23.8%，尤其是在术后前30天。
新型冠状病毒2感染患者的肠道血栓形成会增加死亡率。
